Phase III clinical trial comparing the efficacy and safety of adamgammadex with sugammadex for reversal of rocuronium-induced neuromuscular block.
Zhang Y, Jiang Y, Lei Q, Li C, Jin S, Wang Q, Huang Y, Li Y, Hong Y, Wang S, Lin H, Li H, Ou Y, Zou X, Sun Q, Guo Q, Chen Z, Min S, Qi Y, Jie Q, Liu J, Liu B, Zhang W.
Zhang Y, et al. Among authors: jie q.
Br J Anaesth. 2024 Jan;132(1):45-52. doi: 10.1016/j.bja.2023.10.022. Epub 2023 Nov 25.
Br J Anaesth. 2024.
PMID: 38007377
Clinical Trial.